drug
AI-designed miniproteins target GPCRs in drug discovery
AI-designed miniproteins target GPCRs in drug discovery Drug Target ReviewSee more headlines and perspectives on Google News
RAS Drug Nearly Doubles Survival in Mets Pancreatic Cancer
RAS Drug Nearly Doubles Survival in Mets Pancreatic Cancer MedscapeBreakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an…